Back

New treatment strategies based on the pathophysiology of Group 2 pulmonary hypertension

1 September 2025 (08:15 - 08:30)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: evolving strategies in diagnosis and management Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Taijyu Satoh

Tohoku University Hospital, Sendai (Japan)

3 More presentations in this session

Presentation thumbnail
Chronic thromboembolic pulmonary hypertension: alternative anticoagulation with edoxaban to vitamin K antagonists and emerging early diagnostic modality with dynamic chest radiography
Associate Professor K. Hosokawa (Fukuoka, JP)
Slides
Presentation thumbnail
Microvesicle markers of pulmonary hypertension
Doctor A. Garcia-Alvarez (Barcelona, ES)
Slides
Presentation thumbnail
Prediction models and scores in pulmonary hypertension
Doctor S. Mouratoglou (Thessaloniki, GR)
Slides

Access the full session

Session thumbnail
Pulmonary hypertension: evolving strategies in diagnosis and management
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 08:15 CET
You may be interested in
thumbnail
Congress Session
Pulmonary hypertension: evolving strategies in diagnosis and management
thumbnail
Congress Session
One year after the ESC/ERS pulmonary hypertension Guidelines - how are they affecting our practice?
thumbnail
Congress Session
Phenotypes and management strategies in pulmonary hypertension

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources